By targeting both bone cell activity and immune response and improving imaging data interpretation, doctors can better distinguish diabetic foot infection from another common foot condition that often requires an additional bone-marrow scan for definitive diagnosis, say researchers presenting a study at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance (PET/MR) imaging is the prevalence of motion artifacts—blurring and ghostly visual anomalies caused by patient motion on the table during imaging. An MR technology has now been designed for PET/MR that employs tiny radiofrequency solenoids—metal coils integrated into hardware placed on the body—to track motion from those who do not or cannot stay put. Special software can then use the additional information provided by the coils to optimize the image, according to research being revealed at SNMMI’s 2013 Annual Meeting.

HIMSS Analytics recognizes six Legacy Health hospitals, and their ambulatory clinics, located in Portland, Ore. and Vancouver, Wash., with the HIMSS Stage 7 Award, and Stage 7 EMR Ambulatory Award.

Biopharmaceuticals Inc. announced results from two separate studies that compared the performance of Lymphoseek (technetium Tc 99m tilmanocept) Injection, a novel receptor-targeted small-molecule radiopharmaceutical recently approved by the U.S. Food and Drug Administration, with that of radiolabeled sulfur colloid in breast cancer patients undergoing diagnostic evaluation in lymphatic mapping procedures. The studies were presented in oral presentations at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver, Canada.

Use of computed tomography (CT) scans — and thus exposure to ionizing radiation — increased over 15 years in children at a set of nonprofit health care delivery systems in a new study. But currently available strategies could greatly reduce this cancer risk, according to the HMORN Cancer Research Network study, published in JAMA Pediatrics.

Use of the newer intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.